ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Quick Stats
Feb 03, 202654.1
AI Score
HOLD0.09
Volume Ratio
Feb 27, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
ANIP Stock Summary
Last updated Feb 03, 2026
ANIP is currently trading at $81, positioned above its 200-day moving average of $78.92, indicating a long-term uptrend. The stock has a 52-week range of $54.1 to $99.5.
Technical Analysis: The 50-day moving average stands at $81.75, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 47.211, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.057, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ANIP at 54.1/100 with a HOLD recommendation.
ANIP (ANI Pharmaceuticals, Inc.) Indicators
Last updated Feb 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 47.211 |
| CMF (20) | -0.057 |
| ROC (10) | -5.561 |
| ADX (14) | 24.98 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.325 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -67.67 |
| MFI (14) | 42.982 |
ANIP Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ANIP Price vs Max Options Open Interest
ANIP Max Change In Options Open Interest
ANIP Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANIP Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANIP Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANIP Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANI Pharmaceuticals, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ANIP Moving Averages Analysis
ANI Pharmaceuticals, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 03, 2026
ANIP (ANI Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated Feb 03, 2026
| Days | MA |
|---|---|
| 10 | 82.0 |
| 20 | 82.09 |
| 30 | 81.59 |
| 50 | 81.75 |
| 100 | 86.78 |
| 200 | 78.92 |
ANIP Fundamental Analysis
| P/E (Forward) | 9.6061 |
| P/E (Trailing) | 51.1563 |
| Market Cap ($) | 1.8 billion |
| Earnings/Share ($) | 1.6 |
| Net Proft Margin (%) | 0.0491 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 7.5654 |
| EPS Estimate Next Year ($) | 8.3619 |
| WallStreet Target Price ($) | 110.375 |
| Most Recent Quarter |